Noninvasive assessment of left atrial function by strain rate imaging in patients with hypertension: A possible beneficial effect of renin-angiotensin system inhibition on left atrial function

Hypertension Research

Volumn 30, Issue 1, 2007, Pages 13-21

  Kokubu, Nobuaki ^a   Yuda, Satoshi ^a   Tsuchihashi, Kazufumi ^a   Hashimoto, Akiyoshi ^a   Nakata, Tomoaki ^a   Miura, Tetsuji ^a   Ura, Nobuyuki ^a   Nagao, Kazuhiko ^b   Tsuzuki, Masahiro ^b   Wakabayashi, Chikashi ^b   Shimamoto, Kazuaki ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Sapporo Gorinbashi Orthopaedic Hospital   (Japan)

Author keywords

Hypertension; Left atrium; Renin angiotensin system inhibitors; Strain rate imaging

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; RENIN INHIBITOR;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ECHOCARDIOGRAPHY; FEMALE; FUNCTIONAL ASSESSMENT; HEART ATRIUM ENLARGEMENT; HEART DILATATION; HEART FUNCTION; HEART LEFT ATRIUM; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NON INVASIVE MEASUREMENT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; STRAIN RATE IMAGING;

AGED; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ATRIAL FUNCTION, LEFT; ECHOCARDIOGRAPHY; FEASIBILITY STUDIES; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; MODELS, CARDIOVASCULAR; RENIN-ANGIOTENSIN SYSTEM; REPRODUCIBILITY OF RESULTS;

EID: 33847031658     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.30.13     Document Type: Article

References (30)

1. Pearson AC, Gudipati C, Nagelhout D, Sear J, Cohen JD, Labovitz AJ: Echocardiographic evaluation of cardiac structure and function in elderly subjects with isolated systolic hypertension. J Am Coll Cardiol 1991; 17: 422-430.
2. Cuspidi C, Meani S, Fusi V, et al: Prevalence and correlates of left atrial enlargement in essential hypertension: role of ventricular geometry and the metabolic syndrome. The Evaluation of Target Organ Damage in Hypertension study. J Hypertens 2005; 23: 875-882.
3. Verdecchia P, Reboldi G, Gattobigio R, et al: Atrial fibrillation in hypertension: predictors and outcome. Hypertension 2003; 41: 218-223.
4. Yamaguchi H, Yoshida J, Yamamoto K, et al: Elevation of plasma brain natriuretic peptide is a hallmark of diastolic heart failure independent of ventricular hypertrophy. J Am Coll Cardiol 2004; 43: 55-60.
5. Goette A, Staack T, Röcken C, et al: Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation. J Am Coll Cardiol 2000; 35: 1669-1677.
6. Nakashima H, Kumagai K, Urata H, Gondo N, Ideishi M, Arakawa K: Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation. Circulation 2000; 101: 2612-2617.
7. Shi Y, Li D, Tardif JC, Nattel S: Enalapril effects on atrial remodeling and atrial fibrillation in experimental congestive heart failure. Cardiovasc Res 2002; 54: 456-461.
8. Healey JS, Baranchuk A, Crystal E, et al: Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis. J Am Coll Cardiol 2005; 45: 1832-1839.
9. Inaba Y, Yuda S, Kobayashi N, et al: Strain rate imaging for noninvasive functional quantification of the left atrium: comparative studies in controls and patients with atrial fibrillation. J Am Soc Echocardiogr 2005; 18: 729-736.
10. Di Salvo G, Caso P, Lo Piccolo R, et al: Atrial myocardial deformation properties predict maintenance of sinus rhythm after external cardioversion of recent-onset lone atrial fibrillation: a color Doppler myocardial imaging and transthoracic and transesophageal echocardiographic study. Circulation 2005; 112: 387-395.
11. Modesto KM, Dispenzieri A, Cauduro SA, et al: Left atrial myopathy in cardiac amyloidosis: implications of novel echocardiographic techniques. Eur Heart J 2005; 26: 173-179.
12. Abd El Rahman MY, Hui W, Timme J, et al: Analysis of atrial and ventricular performance by tissue Doppler imaging in patients with atrial septal defects before and after surgical and catheter closure. Echocardiography 2005; 22: 579-585.
13. Di Salvo G, Drago M, Pacileo G, et al: Atrial function after surgical and percutaneous closure of atrial septal defect: a strain rate imaging study. J Am Soc Echocardiogr 2005; 18: 930-933.
14. Yuda S, Short L, Leano R, Marwick TH: Myocardial abnormalities in hypertensive patients with normal and abnormal left ventricular filling: a study of ultrasound tissue characterization and strain. Clin Sci (Lond) 2003; 103: 283-293.
15. Levy D, Savage DD, Garrison RJ, Anderson KM, Kannel WB, Castelli WP: Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol 1987; 59: 956-960.
16. Tedesco MA, Di Salvo G, Ratti G, Natale F, Iarussi D, Iacono A: Left atrial size in 164 hypertensive patients: an echocardiographic and ambulatory blood pressure study. Clin Cardiol 2001; 24: 603-607.
17. Stefanadis C, Dernellis J, Toutouzas P: A clinical appraisal of left atrial function. Eur Heart J 2001; 22: 22-36.
18. Barbier P, Alioto G, Guazzi MD: Left atrial function and ventricular filling in hypertensive patients with paroxysmal atrial fibrillation. J Am Coll Cardiol 1994; 24: 165-170.
19. Nagano R, Masuyama T, Naka M, Hori M, Kamada T: Contribution of atrial reservoir function to ventricular filling in hypertensive patients. Effect of nifedipine administration. Hypertension 1995; 26: 815-819.
20. Okazaki H, Minamino T, Tsukamoto O, et al: Angiotensin II type 1 receptor blocker prevents atrial structural remodeling in rats with hypertension induced by chronic nitric oxide inhibition. Hypertens Res 2006; 29: 277-284.
21. Kahn A, Roth ZJ, Schnitzer R, Raisinghani AB, DeMaria AN: Quantitative assessment of left atrial function by 2-D strain imaging: regional variability and findings with abnormal filling dynamics. Circulation 2005; 112 (Suppl): II-429 (Abstract).
22. 1 blockade stimulates extracellular collagen type I degradation and reverses myocardial fibrosis in spontaneously hypertensive rats. Hypertension 2000; 35: 1197-1202.
23. Díez J, Querejeta R, López B, González A, Larman M, Martínez Ubago JL: Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients. Circulation 2002; 105: 2512-2517.
24. Takeuchi K, Ideishi M, Tashiro T, et al: Higher small arterial elasticity in hypertensive patients treated with angiotensin II receptor blockers. Hypertens Res 2005; 28: 639-644.
25. Kumagai K, Nakashima H, Urata H, Gondo N, Arakawa K, Saku K: Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation. J Am Coll Cardiol 2003; 41: 2197-2204.
26. Demellis JM, Vyssoulis GP, Zacharoulis AA, Toutouzas PK: Effects of antihypertensive therapy on left atrial function. J Hum Hypertens 1996; 10: 789-794.
27. Mattioli AV, Bonatti S, Monopoli D, Zennaro M, Mattioli G: Influence of regression of left ventricular hypertrophy on left atrial size and function in patients with moderate hypertension. Blood Press 2005; 14: 273-278.
28. Engelmann MD, Svendsen JH: Inflammation in the genesis and perpetuation of atrial fibrillation. Eur Heart J 2005; 26: 2083-2092.
29. Ciulla MM, Paliotti R, Esposito A, et al: Different effects of antihypertensive therapies based on losartan or atenolol on ultrasound and biochemical markers of myocardial fibrosis: results of a randomized trial. Circulation 2004; 110: 552-557.
30. Shibasaki Y, Nishine T, Masaki H, et al: Impact of the angiotensin II receptor antagonists, losartan, on myocardial fibrosis in patients with end-stage renal disease: assessment by ultrasonic integrated backscatter and biochemical markers. Hypertens Res 2005; 28: 787-795.